ATM antibody (AA 2050-2717)
Quick Overview for ATM antibody (AA 2050-2717) (ABIN1732026)
Target
See all ATM AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 2050-2717
-
Specificity
- Reacts with human and mouse ATM.
-
Purification
- Purified
-
Immunogen
- Synthetic peptide representing a portion of the ATM encoded within exon 53 (aa 2050-2717)
-
-
-
-
Application Notes
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
WB(0.1 - 0.4 μg/mL) IP(10 - 20 μg/mg) -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Tris citrate/phosphate, pH 7-8
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 2 - 8°C. Antibody is stable at 2 - 8°C for 1 year.
-
-
- ATM (Ataxia Telangiectasia Mutated (ATM))
-
Alternative Name
- ATM
-
Background
- Serine-protein kinase ATM Ataxia telangiectasia mutated, A-T mutated Gene name: ATM, AT1, ATA, ATC, ATD, ATE, ATDC, TEL1, TELO1
-
Gene ID
- 472
-
UniProt
- Q13315
-
Pathways
- p53 Signaling, Apoptosis, DNA Damage Repair, Inositol Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus
Target
-